Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA orphan drug grants

Executive Summary

Agency announced in the Jan. 10 Federal Register that it anticipates availability of funds in FY 1986 for 20-30 grants ranging from $20,000 to $70,000 for orphan product clinical trials. Applications must be received by March 11. The earliest beginning date for awards is August 1. Applications should be obtained from and submitted to Kathryn McKnight, State Contracts and Assistance Agreements Branch (HFA-520), FDA, Room 15A-17, 5600 Fishers Lane, Rockville, MD 20857, 301/443-6170.

Latest Headlines
See All
UsernamePublicRestriction

Register

PS009512

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel